Lite Strategy, Inc. (LITS)
Develops experimental cancer drugs in early testing stages
$0.97-0.01%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-80.1%
The outlook
LITS is trading near its 52-week low, positioned just 5% above the bottom of its yearly range. The stock shows mixed momentum relative to its moving averages, and analyst sentiment is decidedly bearish with a score of 23/100. Current price action reflects minimal movement today.
What’s behind the score
Price trendMixed vs its moving averages
52-week range5% of the way from its 52-week low to high
Market cap
$33.0M
52-wk high
$6.00
52-wk low
$0.69
50-day avg
$0.95
200-day avg
$1.32
Trailing P/E
—